Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
RDHL holding history
RedHill Biopharma Ltd. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RDHL overviewAll 13F holders of RDHLFull Q2 2026 holdings
- Shares (Q2 2026)
- 65,321
- Value
- $55.2K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 65,321 | $55.2K | <0.1% | +44,648+216.0% | Added | Holders |
| Q1 2026 | 20,673 | $15.4K | <0.1% | +5,196+33.6% | Added | Holders |
| Q4 2025 | 15,477 | $15.9K | <0.1% | +15,477 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −21,512−100.0% | Sold out | Holders |
| Q1 2025 | 21,512 | $57.2K | <0.1% | +21,512 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −108,570−100.0% | Sold out | Holders |
| Q2 2024 | 108,570 | $40.2K | <0.1% | +108,570 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −55,779−100.0% | Sold out | Holders |
| Q3 2023 | 55,779 | $28.4K | <0.1% | +40,050+254.6% | Added | Holders |
| Q2 2023 | 15,729 | $19.0K | <0.1% | +15,729 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −57,713−100.0% | Sold out | Holders |
| Q1 2022 | 57,713 | $145.0K | <0.1% | −45,049−43.8% | Reduced | Holders |
| Q4 2021 | 102,762 | $265.0K | <0.1% | +62,835+157.4% | Added | Holders |
| Q3 2021 | 39,927 | $183.0K | <0.1% | +39,927 | New | Holders |